LINKS TO MEDIA REPORTS OF GROUP AND COLLABORATIVE ACTIVITIES
2024
-
Professor Steve Rannard awarded Macro Group UK Medal - click here
-
University receives Queen’s Anniversary Prize for Chemistry at Palace ceremony - click here
2023
-
Board of Nufarm Ltd visits Liverpool from Australia - click here
2022
-
YouTube - Microparticle collaboration with Nufarm Ltd - click here
-
RSC Keynote presentation at Lab Innovations 2022 (Birmingham NEC) - click here
-
Polymer Mimetics webpages at Scott Bader - click here
2021
-
Materials World - Enduring effects – materials chemistry’s use in long-acting therapeutics - click here
-
Licensing of LA therapeutics IP to Medicines Patent Pool - click here
-
World AIDS Day: Are long-acting HIV therapies the future? - click here and here
-
New Unilever Radiochemistry Research Fellow - click here
-
Long-acting injectable medicine as potential route to COVID-19 therapy - click here and here
-
Liverpool launches new Centre of Excellence for Long-acting Therapeutics - click here , here and here.
-
Polymer Mimetics opens in Liverpool Science Park - click here and here.
2020
-
University and Scott Bader Company Ltd announce joint venture to develop novel polymer chemistry platform - click here, here, here and here
-
£24m boost for revolutionary long-acting medicine research - click here
-
Long-acting medicines for malaria, tuberculosis and hepatitis C: Repurposing key medicines as long-acting formulations could revolutionise prevention and treatment - click here and here
2019
-
University spin out company appoints Executive Chairman - click here
-
Novel nano-engineered ‘microneedles’ to help HIV drug delivery - click here
2018
-
£3m boost for Liverpool advanced materials and healthcare research - click here
-
Podcast - Nanomedicine shrinks the cost of HIV treatment - click here to access full podcast
-
Accelerating Material Science Discovery - click here
-
New long-acting approach for malaria prophylaxis developed using nanomedicine approach - click here
-
The Liverpool Model: A revolutionary approach to academic-industry engagement - click here
2017
-
New long-acting approach for malaria prophylaxis developed - click here
-
£2.2m collaboration to develop new approaches for HIV therapy - click here
-
USAID consortium Project OPTIMIZE website - click here
-
First in human trials confirm higher bioavailability from UoL HIV nanomedicines - click here, here and here. Click here and here for CROI 2017 presentation
2016
-
New nanomedicine approach aims to improve HIV drug therapies - click here and here
-
Human PK evaluaion of Efavirenz and Lopinavir Nano-formulations in Healthy Volunteers - click here
2015
-
Liverpool partners in first European Nano-Characterisation Laboratory -click here
-
Nanomedicine researchers part of £39m HIV drug therapies consortium - click here; additional reports here and here
-
Outputs, outcomes and impact of MRC research - 2014/15 report - click here
-
University of Liverpool to Licence Patented Solid Drug Nanoparticle Technology to Medicines Patent Pool - click here
-
New partnership paves way for improved HIV tratments through nanomedicine - click here
-
The Medicines Patent Pool (MPP) Signs a Collaborative Agreement with the University of Liverpool to develop HIV Nanomedicines - click here
2014
-
Tracking the effect of revolutionary new medicines - click here
-
Long acting HIV drugs to be developed - click here
-
What nanomedicines will do for us - eventually: Engineering and Technology Magazine - click here
-
Liverpool materials science spin out company launched - click here
-
Nano-sized drug particles to expand HIV treatment further - click here
-
Liverpool represents UK at European nanomedicine day - click here
2013
-
Research and Markets: Global Nanotechnology Drug Delivery Market Report 2013-2016: Market to Grow at a CAGR of 74% over 2012-2016 - click here
-
Liverpool scientists to launch groundbreaking nanomedicine research forum at city’s first Knowledge Festival - click here
-
Beating HIV with a nanosized stick - click for RSC link
-
Negating HIV: novel nanomedicines. International Innovation article - click here
-
Webcast of "Enhanced Pharmacological Properties of Efavirenz Formulated as solid drug Nanoparticles" - 20th Conference on Retroviruses and Opportunistic Infections - Altlanta March 2013 - WEBCAST UNAVAILABLE CURRENTLY- click here for conference report
2012
-
Researchers pioneer world’s first HIV/AIDS nanomedicines - click here - EPSRC link
-
Plastic: How it works - BBC 4 TV series - click here and here and here
-
Negating HIV: Novel Nanomedicines- click here
-
Launching the British Society for Nanomedicine - click here
2011
-
The Chemistry Innovation KTN Award for Knowledge Transfer - click here
-
IOTA Nanosolutions secures financing for Commercialisation of ContraSol Technology - click here and here
2009
-
University awarded £1.7m to develop nanotechnology for use in healthcare - click here
-
Nano-formulations could reduce pesticide doses - click here
2008
-
Opportunities for organic nanoparticles - click here
-
Economic Impact: Spin-out successes - EPSRC Annual Report - click here
-
Nanoparticles Resarch Aids Drug Development - click here
2007
-
NorthWest Regional Development Agency Science and Technology Business of the Year & BIONoW Biomedical Startup of the Year: IOTA NanoSolutions - click here
-
IOTA NanoSolutions wins Merseyside Innovation Award - click here and here
-
IOTA Nanosolutions and Liverpool School of Tropical Medicines Announce Collaboration for Next Generation Anti-Malarial Treatments - click here